Formulation and Drug Delivery

Emergent Dives Further into the Anthrax Treatment and Vaccine Market

March 25, 2015

Emergent BioSolutions announced FDA approval of Anthrasil, an inhalable treatment that targets Anthrax toxins, as well as a contract with BARDA to develop NuThrax, an anthrax vaccine candidate.

FDA Issues Guidance on Environmental Assessments

March 24, 2015

The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.

Novartis' Cosentyx Shows Promise in the Treatment of Psoriasis

March 24, 2015

Clinical trial results suggest that monoclonal antibodies targeting the function of proinflammatory cytokine IL-17A in psoriasis may be significantly superior to other treatments.

FDA Issues Guidance on Lot Distribution Reports for Biologics

March 23, 2015

Guidance provides labeling standards and an implementation guide for electronic submission of lot distribution reports.

Porvair Opens New Facility in Hampshire, UK

March 18, 2015

Member of parliament, Desmond Swayne, will officially open the 42,000-square-foot facility on March 20, 2015.

Catalent Unveils New Organization to Speed Up Drug Development

March 18, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

Sharon Johnson, senior vice president, Global Quality & Regulatory Affairs, will head the organization.